Orgenesis announces collaboration with MangoGen Pharma

Orgenesis announced a collaboration with MangoGen Pharma, initially focused on the pre-clinical development of insulin producing cells using MangoGen’s advanced gene delivery platform. Under this initial collaboration, the companies will work together to develop a complete solution for the delivery of IPC cells to murine animal models. The company also announced that it has been awarded a grant from the Canada-Israel Industrial R&D Foundation to fund this project.
https://thefly.com/landingPageNews.php?id=2838799